Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2314258122
Affiliations:
25
Authors:
36
Go to article
Institutions Authors Share
Garvan Institute of Medical Research, Australia
10.250000
10.250000
 0.28
University of New South Wales (UNSW Sydney), Australia
5.583333
 0.16
Princess Margaret Cancer Centre, U of T, Canada
4.000000
 0.11
The University of Sydney (USYD), Australia
3.083333
 0.09
The Kinghorn Cancer Centre (TKCC), Australia
1.916667
 0.05
Olivia Newton-John Cancer Research Institute (ONJCRI), Australia
1.000000
 0.03
Genentech, Inc., United States of America (USA)
1.000000
 0.03
Peter MacCallum Cancer Centre (Peter Mac), Australia
1.000000
 0.03
Canberra Hospital (TCH), Australia
1.000000
 0.03
Li Ka Shing Faculty of Medicine, HKU, China
1.000000
 0.03
Chris O'Brien Lifehouse, Australia
1.000000
 0.03
Blacktown and Mount Druitt Hospital (BMDH), Australia
0.833333
 0.02
Westmead Hospital (WSLHD), Australia
0.833333
 0.02
La Trobe School of Cancer Medicine, Australia
0.666667
 0.02
The University of Melbourne (UniMelb), Australia
0.666667
 0.02
Concord Repatriation General Hospital (CRG), USYD, Australia
0.500000
 0.01
Monash University, Australia
0.333333
 0.01
Eastern Health, Australia
0.333333
 0.01
University of Technology Sydney (UTS), Australia
0.250000
 0.01
Western Sydney University, Australia
0.250000
 0.01
Royal Prince Alfred Hospital (RPAH), USYD, Australia
0.250000
 0.01
NSW Health Pathology, Australia
0.250000
 0.01
Interested in Immunology?